Coherus Oncology Inc. (chrs 1.5 04/15/26)
13F holders, Q4 2024 (December 31)2holders
0new positions
0sold out
$0.97avg. 13F price*
At the end of Q4 2024, 2 institutions reported holding Coherus Oncology Inc. (chrs 1.5 04/15/26) in their 13F filings, unchanged from Q3 2024. 0 opened new positions and 0 sold out. The largest holders were Jane Street Group, LLC ($2.9M) and Avantax Advisory Services, Inc. ($10K).
- Company
- Coherus Oncology Inc. (chrs 1.5 04/15/26)
- CUSIP
- 19249HAB9
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 2 holders
| Jane Street Group, LLC | 0.00% | No change | 3,000,000 | $2.9M |
| Avantax Advisory Services, Inc. | 0.00% | No change | 10,000 | $10K |
"% of holder's portfolio" is COHERUS ONCOLOGY INC (CHRS 1.5 04/15/26)'s weight in each manager's 13F, not the share of Coherus Oncology Inc. (chrs 1.5 04/15/26) the manager owns.